Innospec

IOSP on Nasdaq. Chemicals & allied products. Market value $2.0bn.

Watch this stockFree. We tell you when something changes.

Price checks use the past 12 months to September 2026. Quality checks use five annual reports, the latest for the year to December 2025.

We can't read total debt from the filing, so debt is left out.

Should I look at this?

Worth a closer look

Read what could go wrong

This is not advice. Check the numbers below.

Compare with another stock

Cash yield
past 12 months to September 2026
1.8%low

For every $100 of what the whole company costs, it produced $1.82 of spare cash in the past 12 months. A savings account pays about $4.

Price to profit
past 12 months to September 2026
n/a

The filings do not give us enough to work this out.

Return on capital
five annual reports to December 2025
n/a

The filings do not give us enough to work this out.

Quality score: 71 of 100. Price score: 60 of 100. Our list needs 70 on quality and 60 on price.

$75.56 a share, 15% above its 1-year low

Over the past year the price has ranged from $65.51 to $102.00.

Dividend: 2.3% a year

Paid every year for at least 5 years

Prices from Friday’s close (20 November).

Five years of cash, in billions

0.1
0.0
0.1
0.1
0.1
0.0
2021202220232024202512 monthsto Sep '26

Spare cash swings from quarter to quarter here: $34 million in the past 12 months, $63 million in the year to December 2025.

Revenue
$1.5bn$2.0bn$1.9bn$1.8bn$1.8bn
Operating margin
8.9%9.5%8.3%9.6%7.3%
Debt to equity
n/an/an/an/an/a
Shares outstanding
0.02bn0.02bn0.02bn0.02bn0.02bn

Health checks

  • Free cash flow positive5 of 5 years
  • Accounting looks honest (Beneish)Not enough data
  • Financial strength (Piotroski)5 of 7 checks we could run
  • Profit backed by cash (accruals)Yes
  • DebtUnknown
  • Revenue growth, five yearsSlow, 8.3% a year
  • Buying back its own sharesRoughly flat

The quarter to September 2026

How the business did, compared with the same quarter a year earlier.

  • Sales: $474 million last quarter, up 7% on a year ago.
  • Profit: $32 million, up 147% on a year ago.
  • It keeps 9 cents of each $1 of sales as operating profit, up from 7 cents a year earlier.
  • Spare cash over the past 12 months: $34 million, up from $29 million.
  • 1% fewer shares than a year ago. Each share owns a bit more of the company.
  • Sales grew on a year ago in 3 of the last 4 quarters.
Sales by quarter
Sales by quarter
Quarter toAmount
December 2024$467m
March 2025$441m
June 2025$440m
September 2025$442m
December 2025$456m
March 2026$453m
June 2026$491m
September 2026$474m
Profit by quarter
Profit by quarter
Quarter toAmount
December 2024-$70m
March 2025$33m
June 2025$24m
September 2025$13m
December 2025$46m
March 2026$30m
June 2026$31m
September 2026$32m

From the company's quarterly reports to the SEC.

Dates

Next results (estimated)
n/a
Last annual report (10-K)
18 February 2026
Next quarterly (estimated, 10-Q)
3 February 2027

Who owns it

4 long-term investors we follow own it, unchanged from 4 last quarter. 282 funds in all.

Jun '25
Dec '25
Jun '26
Largest holders overall

From 13F filings for the quarter ended 30 June 2026.

Big holders and activists

4 investors own more than 5%.

From Schedule 13D and 13G filings: anyone owning more than 5% must file one.

What insiders did

In the last 12 months, 1 insider bought $27,493 of shares on the open market. 6 sold $574,073.

  • PARRETTE LESLIE J
    Director
    Bought
    Date
    10 November 2026
    Shares
    345
    Price
    $79.69
    Value
    $27,493
  • Jones David B.
    SVP, GC & CCO
    Sold
    Date
    3 March 2026
    Shares
    1,028
    Price
    $75.64
    Value
    $77,758
  • Blackmore Milton C
    Director
    Sold
    Date
    27 February 2026
    Shares
    594
    Price
    $76.55
    Value
    $45,473
  • PADFIELD Larry
    Director
    Sold
    Date
    27 February 2026
    Shares
    594
    Price
    $76.55
    Value
    $45,473
  • Poccia Claudia
    Director
    Sold
    Date
    27 February 2026
    Shares
    119
    Price
    $76.56
    Value
    $9,110
  • LANDLESS DAVID
    Director
    Sold
    Date
    27 February 2026
    Shares
    594
    Price
    $76.55
    Value
    $45,473
  • Cleminson Ian
    EVP & CFO
    Sold
    Date
    27 February 2026
    Shares
    2,380
    Price
    $76.55
    Value
    $182,197
  • Blackmore Milton C
    Director
    Sold
    Date
    20 February 2026
    Shares
    1,030
    Price
    $81.84
    Value
    $84,295
  • PADFIELD Larry
    Director
    Sold
    Date
    20 February 2026
    Shares
    1,030
    Price
    $81.84
    Value
    $84,295

From Form 4 filings: insiders must report trades in their own company's shares within two days.

How the boss is paid

Mr. Patrick S. Williams was paid $8.3 million in 2025, about 79 times the typical employee’s pay.

  • The yearly bonus pays for per-share results:

    No — it uses profit and cash flow targets. See it in the filing

  • The long-term stock award pays for per-share results:

    Yes — it uses earnings per share and shareholder return. See it in the filing

Why it matters: new shares can grow total profit while each share earns less. Per-share goals pay the boss only when your slice grows.

From the proxy statement (the company’s yearly voting pack) filed 26 March 2026. Picked out automatically from the company’s own filing. Evidence, not our verdict.

Warning signs in its filings

Problems the company itself reported to the SEC, in its own words.

None of the warning signs we check for were found.

We look for five warning signs: doubt it can keep going, weak checks on its own accounts, a notice that its past accounts can't be relied on, a change of auditor, and one customer bringing in a big share of sales. We don't check lawsuits, investigations or debt yet.

We checked the auditor's report, internal controls, restatement notices, auditor changes and big customers in the 10-K filed 18 Feb 2026, plus the 10-Q filed 4 Nov 2026 and 5 later 8-Ks.

A 10-K is the yearly report every US company files with the SEC. An 8-K is a short notice of a big event.

What could go wrong

Cheap for a reason is the question the numbers cannot answer.

Whether the price already reflects the risks is what the deep dive is for.

What changed in the risks this year

Companies must list what could hurt them each year. These are the parts that changed since last year’s report.

  • Our ability to monitor and manage our business performance is dependent upon the effectiveness of our information technology systems.

    The sales of our AvGas product line for use in aviation gasoline are recorded within our Fuel Specialties business. The piston aviation industry has been, and is currently, researching a safe replacement fuel to replace leaded fuel. The U.S. Federal Aviation Administration (“FAA”) program (Piston Aviation Fuels Initiative) has been established to identify a replacement fuel, and candidate fuels are undergoing testing. In 2022, various general aviation industry groups in conjunction with the US EPA and FAA created a new team named Eliminate Aviation Gasoline Lead Emissions (“EAGLE”). This is a government-industry partnership that also encompasses fuel producers and distributors, airport operators, communities that support general aviation airports, and environmental experts. The most significant announcement impacting the Company is the stated aim of EAGLE to eliminate lead emissions from general aviation in the U.S. by the end of 2030 with Alaska having a derogation out to end 2032. Regulatory action in the EU on the prohibition of TEL use by EU based leaded avgas blenders under the EU REACH Regulations has resulted in three users successfully applying for EU REACH Authorization permitting continued TEL use until end of April 2032.
    Read more

Read it in the annual report

The deep dive

Everything above is arithmetic on public filings. The deep dive reads the last ten years of annual reports, the proxy statements, and the earnings calls, then argues the case the way Buffett, Klarman, and Hohn would, and checks every claim against the source.

  • What the business is worth, as a range, and the margin of safety at today’s price
  • Prices to start buying, buy, and buy hard
  • The three things that would make this a mistake
  • Every number footnoted to the filing it came from

It just passed both our tests. The deep dive checks what the numbers can't.

Create a free account to run it

Your first deep dive is free.

What a finished deep dive looks like

Not advice. Numbers on this page come from SEC filings and are updated each night; prices are updated again after the US market closes. The five-year figures are rounded.